Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
20121.8k citationsChristian Simader, Ursula Schmidt‐Erfurth et al.profile →
The RESTORE Study
20111.0k citationsUrsula Schmidt‐Erfurth, Christian Simader et al.profile →
f-AnoGAN: Fast unsupervised anomaly detection with generative adversarial networks
2019845 citationsThomas Schlegl, Sebastian M. Waldstein et al.profile →
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
2019623 citationsUrsula Schmidt‐Erfurth et al.profile →
Artificial intelligence in retina
2018521 citationsUrsula Schmidt‐Erfurth, Bianca S. Gerendas et al.Progress in Retinal and Eye Researchprofile →
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
2014478 citationsUrsula Schmidt‐Erfurth et al.British Journal of Ophthalmologyprofile →
Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
2017464 citationsUrsula Schmidt‐Erfurth, Bianca S. Gerendas et al.profile →
Fully Automated Detection and Quantification of Macular Fluid in OCT Using Deep Learning
2017422 citationsThomas Schlegl, Sebastian M. Waldstein et al.profile →
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration
2015294 citationsUrsula Schmidt‐Erfurth, Sebastian M. WaldsteinProgress in Retinal and Eye Researchprofile →
HAWK and HARRIER
2020260 citationsUrsula Schmidt‐Erfurth et al.profile →
2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations
2018206 citationsReinhard Told, Stefan Sacu et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Ursula Schmidt‐Erfurth
Since
Specialization
Citations
This map shows the geographic impact of Ursula Schmidt‐Erfurth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Schmidt‐Erfurth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Schmidt‐Erfurth more than expected).
Fields of papers citing papers by Ursula Schmidt‐Erfurth
This network shows the impact of papers produced by Ursula Schmidt‐Erfurth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Schmidt‐Erfurth. The network helps show where Ursula Schmidt‐Erfurth may publish in the future.
Co-authorship network of co-authors of Ursula Schmidt‐Erfurth
This figure shows the co-authorship network connecting the top 25 collaborators of Ursula Schmidt‐Erfurth.
A scholar is included among the top collaborators of Ursula Schmidt‐Erfurth based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Ursula Schmidt‐Erfurth. Ursula Schmidt‐Erfurth is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Riedl, Sophie, Wolf‐Dieter Vogl, Sebastian M. Waldstein, Hrvoje Bogunović, & Ursula Schmidt‐Erfurth. (2020). Fluid Persistence and its Impact on BCVA Development During the Treatment of Neovascular AMD. Investigative Ophthalmology & Visual Science. 61(7). 3505–3505.1 indexed citations
8.
Sacu, Stefan, Katharina Eibenberger, Michael Georgopoulos, et al.. (2015). Effects of dexamethasone intravitreal implant on macular morphology, macular function, retrobulbar blood velocity and oxygen saturation in retinal vessels in patients with macular edema secondary to retinal vein occlusion. Investigative Ophthalmology & Visual Science. 56(7). 3751–3751.1 indexed citations
9.
Podkowinski, Dominika, Jing Wu, Bianca S. Gerendas, et al.. (2015). The foveal shape is not predictive of visual acuity and treatment response in macular edema due to retinal vein occlusion. Investigative Ophthalmology & Visual Science. 56(7). 5927–5927.1 indexed citations
10.
Prager, Sonja, et al.. (2015). Thinning of the central neurosensory retina during anti-VEGF treatment of diabetic retinopathy.. Investigative Ophthalmology & Visual Science. 56(7). 1736–1736.1 indexed citations
11.
Gerendas, Bianca S., Sebastian M. Waldstein, Jan Lammer, et al.. (2012). Centerpoint Replotting And Its Effects On Central Retinal Thickness In Four Prevalent SD-OCT Devices. Investigative Ophthalmology & Visual Science. 53(14). 4114–4114.2 indexed citations
12.
Prager, Sonja, Katharina Kriechbaum, Georgios Mylonas, Gregor Rainer, & Ursula Schmidt‐Erfurth. (2010). Comparison of Intravitreally Applied Bevacizumab and Triamcinolone on Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 51(13). 4262–4262.1 indexed citations
13.
Sacu, Stefan, Panagiotis Malamos, Michael Georgopoulos, Christian Pruente, & Ursula Schmidt‐Erfurth. (2009). Correlation of High-Definition Optical Coherence Tomography and Fluorescein Angiography Imaging in Neovascular Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 50(13). 5260–5260.1 indexed citations
14.
Bolz, Matthias, Christian Pruente, Thomas Benesch, et al.. (2008). The Relevance of Measuring Central Retinal Thickness During Intra-vitreal Therapy With Ranibizumab: Analyzing a Multi-Center Clinical Trial. Investigative Ophthalmology & Visual Science. 49(13). 5576–5576.2 indexed citations
15.
Michels, Stephan, et al.. (2006). VEGF 165 Serum Levels Following Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 47(13). 2173–2173.1 indexed citations
16.
Prager, Franz, Stephan Michels, W. Geitzenauer, & Ursula Schmidt‐Erfurth. (2006). Comparison of Early Response to Systemic or Intravitreal Bevacizumab (Avastin®) in Patients With Neovascular AMD. Investigative Ophthalmology & Visual Science. 47(13). 5245–5245.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.